Today, a combination of public investment, biotechnology development, and the digitization of health profiles has evolved personalization beyond therapy selection and into the realm of drug discovery, how care is planned and delivered, and increasingly, how we as individuals/patients engage with companies seeking to improve health.
Advances in diagnostics, digital devices, and imaging are driving this transformation, alongside an arsenal of analytic tools working across a multitude of institutions and stakeholders. Moreover, acceleration of data generation, advances in developing insights, and personalization of the healthcare ecosystem have added dimensionality to Precision Medicine.
Encompassing this entire ecosystem, medicine will be driven by three key components:
1) Data collection through diagnostics and behavioral devices that capture individuals in various states of health and disease;
2) Individualized solutions through advanced analytic engines and personalized therapies;
3) Business models, which are necessary to sustain value and incentivize continued growth.